Week 1 Pharmacodynamics and pharmacokinetic Flashcards

1
Q

Pharmacodynamics

A

Pharmacodynamics
Defined as “ The actions of a drug on the body”
“What does the drug do to the body? ”
Describes a drug’s molecular, biochemical, and physiologic effects or actions occurring by binding to specialized target macromolecules (receptors) on or in the cell.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Drug-receptor complex

A

Starts biological molecular activities by signal transduction
Magnitude of cellular response: proportional to the number of drug-receptor complex
More drug binding to receptor more physiological receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Transmembrane ligand-gated(subtance/drug-gated) Ion Channels

A

Regulates cellular access of soluble ions (Na++, K+)

Ligand-binding area is on the cell membrane

Key feature: downregulation of receptors

Receptors may be internalized within the cell, making them unavailable for further agonist interaction ability to hide within the cell, leading to no more binding in the cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

G-Protein-Coupled Receptors

A

Generate intracellular second messengers to initiate cellular cascade for intracellular effect.

Has ability to amplify signal intensity and duration

Example: Alpha- and beta- adrenergic receptors; hormone receptors

When hormone or drug bind the receptor, it changes the receptor shape, leading it to interaction to G protein (GTP to GDP), alpha and other attaches itself to acti adenyly cyclase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Enzyme-linked Receptor(insulin receptor or growth factor receptor)

A

Increase intracellular enzyme activity (tyrosine kinase) -> ^ autophosphorylation
Last for minutes to hrs
Has ability to amplify signal intensity and duration
Ex: Growth factor and insulin receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Intracellular receptors

A

Cytoplasmic receptors,
Respond to lipid soluble ligand molecules
Drug attaches to receptor -> Moves into nucleus -> initiates DNA transcription -> mRNA -> specific proteins -> biologic effects
The effect of drugs or endogenous ligands that activate intracellular receptors takes hours to days to occur.
Ex: steroid and thyroid hormones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Initial small signal gets amplified in the signal pathways (Signal Cascade Effect)

A

Need only a fraction of the total receptors for a specific ligand to be occupied to elicit a maximal response.

Some receptors are “spare”
About 99% of insulin receptors are “spare,”

Provides an immense functional reserve that ensures that adequate amounts of glucose enter the cell.
Only about 5% to 10% of the total β-adrenoceptors in the heart are spare.
Little functional reserve exists in the failing heart, because most receptors must be occupied to obtain maximum contractility.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Down regulation

A

Reduced synthesis of new receptors

Usually happens with repeated exposure to an agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Sequestration or Internalization

A

Sequestration or Internalization
Degradation of preexisting receptors through endocytosis
Usually happens with repeated exposure to agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Up-regulation of receptors

A

Receptor reserves are inserted into the membrane, increasing the number of receptors available.
Usually happens with repeated exposure of a receptor to an antagonist
Can make cells more sensitive to agonists and/or more resistant to effects of the antagonist.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Desensitization or Tachyphylaxis

A

A rapid decrease in response (effects of medication) to chronic, repeated exposure to agonist over a short time period , (Could occur at the initial dose)

Etiologies
Downregulation or sequestration of receptors
Exhaustion of secondary messengers
^ metabolic degradation of the medications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Tolerance

A

A slow decrease in response to chronic, repeated exposure to agonist
Seen in chronic opioid users: Target receptors are reduced -> higher dose is needed to have same benefit

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Potency

A

requires less amount to produce therapeutic effect

A measure of the amount of drug necessary to produce a given effect.
Indicated as half maximal effective concentration (EC50)
The concentration of drug producing 50% of the maximum effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Efficacy

A

The magnitude of response when a drug interacts with a receptor
Dependent on the number of drug–receptor complexes and the intrinsic activity of the drug
The relative ability of agonist to fully or partially activate receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Maximal efficacy of a drug (Emax)

A

Occurs when the drug occupies all receptors (generally meds have a maximum dose because after taking a certain amount, it is found that no matter how much more you take will not increase the efficacy of the drug)

No increase in response to higher concentrations of drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Intrinsic activity of drugs

A

A measure of the ability of a drug in producing a change in cellular activity when it binds to the receptors
Determines its ability to fully or partially activate the receptors.
Drugs may be categorized according to their intrinsic activity and resulting Emax values

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Affinity

A

A measure of the tightness with which a drug binds to the receptor
Higher affinity -> Higher potency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Ligands

A

: endogenous hormones or neurotransmitters (ex: adrenalines: norepinephrine, epinephrine)
Bind to the specific receptors that results in physiological response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

synthetic ligands

A

Drugs: synthetic ligands (i.e thyroid meds, bind to thyroid sites)
Receptors:
Protein molecules
Located on the organs of our body ( inside the cell or on its membrane)
Bind to specific ligands: Causes physiological responses in our body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Full Agonists

A

Produce a maximal biologic response(Same Emax) that mimics the response to the endogenous ligand that is supposed to bind to the receptor

Eg:
Phenylephrine is a full agonist at α1-adrenoceptors
Produces the same Emax as the endogenous ligand, norepinephrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Partial Agonists

A

Cannot produce the same Emax as a full agonist even when all the receptors are occupied

May function as antagonist when given with full agonist

Compete for receptors with full agonist

Emax of a full agonist would decrease until it reached the Emax of the partial agonist.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Competitive reversible Antagonist

A

Characteristic shift of the agonist dose–response curve to the right (increased EC50 ) without affecting Emax

Eg: Terazosin (compete with natural neurotransmitter , epinephrine at α1-adrenoceptors)

Requires more epinephrine given to get the same result when given with terazosin since terazosin also competes to binding site (competitive reversib le antagonist - but removable when have enough agonist)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Competitive Irreversible Antagonist

A

Competes for the same sites of the receptors with agonist

Binding is not reversible
Permanently reduce the number of receptors available to the agonist

Causes a downward shift of the Emax, with no change EC50 values

Addition of more agonist does not overcome the effect of irreversible antagonists.

Competitive irreversible antagonist will not come off of the recetpro

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Allosteric (Noncompetitive) antagonist

A

Binds to a site (allosteric site) other than the agonist-binding site and prevents receptor activation by agonist

Irreversible binding
Causes a downward shift of the Emax of an agonist, with no change in the EC50 value.

Competitive reversible antagonists reduce agonist potency (increase EC50)

Competitive irreversible antagonist and noncompetitive antagonists (allosteric antagonist) reduce agonist efficacy (decrease Emax).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Effective Dose (ED 50)

A

Effective Dose (ED 50):the dose of a drug that produces, on average, a specified all-or-none response in 50% of a test population

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Toxic Dose (TD50):t

A

Toxic Dose (TD50):the dose required to produce a particular toxic effect in 50% of a test population

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Lethal Dose (LD 50):

A

Lethal Dose (LD 50): the dose required to kill 50% of a test subject population

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Therapeutic Index

A

Therapeutic Index
Determined using drug trials and accumulated clinical experience
Reveal a range of effective doses and a different (sometimes overlapping) range of toxic doses
High TI values are required for most drugs
Some drugs with low therapeutic indices are routinely used to treat serious diseases
When the risk of experiencing adverse effects is not as great as the risk of leaving the disease untreated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

First pass effect

A

phenomenon of drug metabolism whereby the concentration of a drug, specifically when administered orally, is greatly reduced before it reaches the systemic circulation. It is the fraction of drug lost during the process of absorption which is generally related to the liver and gut wall

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What is Pharmacokinetics?

A

What the body does to the drug?
Absorption: how the drug gets into the body
Distribution: where the drug goes to in the body
Metabolism: how the body chemically modifies the drug
Excretion: how the body gets rid of the drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Absorption

A

Site: gut to plasma
bio availability

factors: drug characterisitcs, blood flow, cell membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Distribution

A
sites: plasma to tissue
volume of distribution
phases: 
1) blood flow from site of adminstration
2) delivery of drug into tissues at site of drug actiob
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Biotransformation (Metabolism)

A

Site: liver
enzyme inhibition/induction
first pass effect

phase1: oxydation cytochrome P450
phase2: glucuronidation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Elimination

A

Site: kidney

clearance, halflife, steady state, linear/nonlinear kinetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

4 ways of Absorption from GI tract

A

Passive Transport:
Passive diffusion,
Facilitated diffusion

Active Transport: requires energy
Endocytosis: large molecule transport

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Strong acid or base

A
Completely dissociate in water
Completely polarized (Ionized or charged) in water
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Weak acid or base

A
Partially dissociate in water
Partially polarized (Ionized or charged)) in water
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Passive diffusion

A

No energy expenditure by cell
Movement through the concentration gradient: move from high concentration to low concentration

Ficks Law: “The greater the distance and the larger the molecule, the slower the diffusion rate”

Majority of drugs are absorbed by passive diffusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Facilitated Diffusion

A

Movement through the concentration gradient

Does not require energy

Process that uses drug transporter protein
Facilitate the passage of large molecules

Drug transporters undergo conformational changes
Allow the passage of drugs or endogenous molecules into inside of cells.

Can be saturated

May be inhibited by compounds that compete for the drug transporter (transporter in use, unable to transport others)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Active Transport

A

Protein molecules act as transporters across cell membrane
Large molecules can enter the cells via this process
Molecule from lower concentration to high concentration, uses ATP - energy to bring large molecules into high concentration area
Selective permeability of cell membrane: Ability to differentiate between different types of molecules
Requires energy expenditure

41
Q

Absorption_Endocytosis

A

Used to transport drugs of exceptionally large molecular size
Involves engulfment of a drug by the cell membrane and transport into the cell by pinching off the drug-filled vesicle.

Vitamin B12 is transported across the gut wall by endocytosis

42
Q

Factors Affecting Absorption

A

pH of the environment where drug is in
Blood flow to the absorption site
Expression of P-glycoprotein (Drug transporter molecules)\
Total surface area available for absorption
Contact time at the absorption surface
pH of the environment where drug is in
Blood flow to the absorption site
Expression of P-glycoprotein
Total surface area available for absorption
Contact time at the absorption surface

43
Q

Pharmacokinetic vs Pharmacodynamics

A

Pharmacokinetic interactions
ADME properties of the drug is altered by the precipitants

Pharmacodynamic Interactions
The activity of the object drugs at its side of action is altered by the precipitant

44
Q

Distribution

A

Altered distribution pattern of the drug by affecting the protein-binding capacity of the drug (Object drug)

Precipitant drug may displace the drug (Object drug) from it’s binding site

Increases the amount of free, circulating drug

May lead to toxicity

Usually transient because free drug is subject to metabolism

Clinically significant drug displacement interactions occur when:

Drugs are > 90% protein bound and
Narrow therapeutic index

45
Q

Excretion

A

Acidification or alkalinization of urine

Urine pH determines the ionization state of the excreted molecule

Ionized molecules become trapped in urine and are excreted

Weak acidic medication is combined with alkaline urine in kidney, like weak basic medication is combined with acidic urine in kidney, ionized molecule become trapped and unable to reutn back to the bloodstream/become reabsorbed

46
Q

How does high fat food affect drug absorption?

A

Increase absoprption rate of lipophilic drugs

47
Q

How does diary product affect drug absorption?

A

bioavalibility of tetracyclin and fluoroquinolone antibodies

48
Q

How does orange, tomato, grapefruit juice: alkaline urine affect drug absorption?

A

bioavalibilty of weak base drugs P450 interaction with grapefruit juices

49
Q

How does Rich in Vit K affect drug absorption?

A

opposte the anti coagulartory efficacy of warfarin

50
Q

How does rich in tyramine affect drug absorption?

what food is rich in tyramine?

A

(aged cheese, dry type summer sausage, pepperoni, salami)
precipitate a hypertensive crisis in patient with MAO inhibitors

MAOI increase breakdown and absorption of tyramine

51
Q

How does acacia- fiber suppliement affect drug absorption?

A

slows or reduce absoprtion of amoxicillin

doses should be separated by 4 hours

52
Q

How does St. John’s wort affect drugs?

A

induces CYP3A4, 2E1, 2C19
clinically signifi ant interaction with immunosupressant, hypoglucemics, anti inflammatory agents, antimicrobial agents, anti migraine medication, oral contraceptives, cardiovascular agents, antivirtals, CNS, GI, respiraotry agents,

53
Q

GI transit time (GI Motility) delayed by

A

High fat meals
Solid foods: The presence of food in the stomach both dilutes the drug and slows gastric emptying. Therefore, a drug taken with a meal is generally absorbed more slowly
Diarrhea : Drug moves through the GI tract very fast. Lower absorption

54
Q

Bioavailability:

A

The % of the drug that reaches the systemic circulation
Depends upon the route of administration and ability to pass through membranes or barriers in the body
IV = 100% bioavailability
PO = Variable
calculated based on AUC
Area Under Curve(AUC):Represents the total exposure to a drug that the body receives.

55
Q

First pass metabolism ( First pass effect)

A

A phenomenon in which a drug gets metabolized at a specific location in the body
Results in a reduced concentration of the active drug upon reaching its site of action or the systemic circulation.
Affects efficacy of the drug, may require higher dose?
Often associated with the liver, as this is a major site of drug metabolism.
Also occur in the lungs, vasculature, gastrointestinal tract, and other metabolically active tissues in the body
Crucial to the proper administration and maintenance of pharmacological therapy.

56
Q

Factors Affecting Bioavailability

A

First-Pass metabolism
Solubility of the drugs
Chemical instability transportation
Nature of the drug formulation

57
Q

For a drug to be readily absorbed, it needs to be what?

A

Very hydrophilic drugs: Poorly absorbed because of the inability to cross lipid-rich cell membranes.
Extremely lipophilic drugs: Poorly absorbed, because they are insoluble in aqueous body fluids

For a drug to be readily absorbed
Must be largely lipophilic
Yet have some solubility in aqueous solutions.
This is one reason why many drugs are either weak acids or weak bases.

58
Q

Expression of P-glycoprotein

Transmembrane drug transporter protein:

A

Function as efflux pump, pumping its substrates from inside to outside the cell.
Affects the plasma and tissue concentrations of the drugs and ultimately the final effects.
Known as multidrug resistance protein 1 (encoded by MDR1)
High expression of this protein pump reduces absorption

59
Q

Stomach and Duodenum have what kind of pH

A

acidic pH
Weak acid drug with more non-ionization
Become more nonionized when pH is decrease
Better absorption
Due to thick mucus in the stomach, poor absorption even if weak acid meds

60
Q

Ileum’s pH is

A

: Alkaline pH

Weak base drug becomes more nonionized

61
Q

Absorption

A

: how the drug gets into the body

62
Q

Distribution

A

: where the drug goes to in the body

63
Q

Metabolism

A

: how the body chemically modifies the drug

64
Q

Excretion

A

: how the body gets rid of the drug

65
Q

What are the two phases of biotransformation and what do they do

A

Phase 1: Oxidation, hydrosis or reduction
Drug changed to form a more polar or water-soluble compound
Involves Cytochrome P450 (CYP) system

Phase 2: Conjugation (Glucuronidation)
Adds a conjugate (glucuronide and others) to the parent drug or phase 1 metabolized drug to increase water- solubility and enhance excretion.

66
Q

What is Phase 1 of biotransformation in the liver?

A

Oxidation, hydrosis or reduction

Drug changed to form a more polar or water-soluble compound
Involves Cytochrome P450 (CYP) system

67
Q

What is Phase 2 of biotransformation in the liver?

A

Conjugation (Glucuronidation)
Adds a conjugate (glucuronide and others) to the parent drug or phase 1 metabolized drug to increase water- solubility and enhance excretion.

68
Q

Cytochrome P 450 (CYP ) enzymes in Phase I

A

A protein superfamily of heme-containing isoenzymes located in most cells.
Primarily in the liver and GI tract- where its converted into forms that can be excreted
Considerable genetic variability
Poor metabolizer vs rapid metabolizer
May alter drug efficacy and the risk of side effects

69
Q

What are the three types of P450 enzymes

A

substrate, inducer, or inhibitor

70
Q

What is a substrate

A

Drugs utilize CYP enzymes for normal metabolization​
Drugs are metabolized by using the enzyme
There may be some inducer to increase the process of the enzyme activity, but CYP2D6 doesnt have inducer

71
Q

What is a Inducer?

A
  • increase elimination of
    Drugs that stimulates the production of enzyme available to metabolize certain drugs​
    Will increase metabolism​ of certain drugs
    Could result in less efficacy ​of certain drugs
    Ex: Rifampin (Inducer) for HIV protease inhibitor
    Enzyme induction and inhibition are the basis of metabolically-mediated drug-drug interactions

If takes drugs that are inducers the drug that is taken will be excreted out faster
It taken 2 drugs, a common substrate and a inducer, the dosage may need to be increased to provide the same effect

72
Q

What is a Inhibitor

A
  • slow down elimination of
    Drugs that inhibit the production of an enzyme and thereby decreases the metabolism of certain drugs.​
    Will slow down elimination of certain drugs​
    Could result in increased concentration of certain drugs
    Could result in adverse effects​ of certain drugs
    Ex: Omeprazole (Inhibitor) for Warfarin​
73
Q

Polymorphism

A

​: The presence of genetic variances in single gene that result in the different phenotypes.

74
Q

What is biotransformation?

A

(drug metabolism) - usually happens in liver, its elimination of drug

Necessary steps for change of drugs into water-soluble forms to be easily excreted.

Active form of drug to inactive form through metabolism to be excreted by kidney or in bile.

The kidney cannot efficiently excrete lipophilic drugs - usually passes the cell membrane of kidneys very well leading to reabsoprtion in distal convulented tubules
Waterphilic gets excreted faster
Primarily occurs in the liver: Phase I and II Reaction

75
Q

what is Pharmacogenomics

A

Relatively new field combines pharmacology (the science of drugs) and genomics (the study of genes and their functions)
The study of how genes affect a person’s response to drugs
To develop effective, safe medications and doses that will be tailored to a person’s genetic makeup

76
Q

What are 3 factors that affects Distribution

A

Cardiac output/local blood flow to the area of action
Capillary permeability- how well the medication can go through capillary tells ho far the medication can go through tissue
Degree of binding of the drug to plasma proteins or tissue proteins

77
Q

What are the 3 Plasma proteins:

A

Albumin, Globulin, Fibrinogen

78
Q

What does Albumin do?

A

The most abundant / Made by the liver
Transport vehicles for fatty acids and steroid hormones (Binding protein)
Bind to various substances
The most significant contributor to the osmotic pressure of blood
Holds water inside blood vessle, and draw the volume from outside the wall into the wall

79
Q

What does Globulin do?

A

The gamma globulins
Involved in immunity
Known as an antibodies or immunoglobulins.
Alpha, beta globulins :
Transport iron, lipids, and the fat-soluble vitamins A, D, E, and K to the cells
Contribute to osmotic pressure

80
Q

What is Fibrinogen?

A

Essential for blood clotting

81
Q

What is Volume of Distribution (Vd)?

A

Hypothetical volume

Defined as the fluid volume that is required to contain entire drug in the body at the same concentration measured in the plasma

Reflects the extent to which the drug is present in extravascular tissues but not in plasma.

Vd = dose / plasma concentration

It can be expressed as liters or indexed to body mass in L/kg.

82
Q

What does a drug with high Vd mean?

A

Leave the plasma and enter the extravascular compartments of the body
High Vd -> More distribution to other tissue
A higher dose of a drug is required to achieve a given plasma concentration.

83
Q

What does a drug with low Vd mean?

A

Remains in the plasma
(Low Vd -> Less distribution to other tissue)
A lower dose of a drug is required to achieve a given plasma concentration.

84
Q

What are the effect of Vd on drug half life?

A

A drug with a high Vd

Most of drugs in the extra-plasma space ->Not readily available for elimination.

So it takes longer time to be eliminated -> Half-life is longer

85
Q

What is Cmax?

A

: The highest drug concentration in the body

86
Q

What is tmax?

A

: Time at which the highest concentration occurs

87
Q

What is T1/2 (Half Life) ?

A

T1/2 (Half Life) : Time taken to remove the half of the current concentration of the drug from the body

88
Q

What is AUC: (Area Under the Curve)?

A

Represents the total exposure to a drug that the body receives. AUC shows how high the concentration [C] of the drug gets, as well as how quickly it is excreted

89
Q

Between lipophilic drugs and waterphili drugs, which gets excreted faster via kidney?

A

waterphilic

90
Q

Elimination can happen which 2 ways?

A

By excretion of an unmetabolized drug in its intact form by kidney
or
By metabolic biotransformation followed by excretion

91
Q

What organs take part in excretion?

A

By several organs: Kidneys, GI tract (feces and biles), lungs, skin, mammary glands, sweat glands, salivary glands.

92
Q

What are the steps to renal excretion?

A

Glomerular filtration
Proximal tubular secretion - water soluble medication gets excreted with energy, non polarized, lipid soluble drugs goes via passive diffusion
Distal tubular reabsorption - most of the nonpolizated will get back into capillary nephron
At the end, excretion have the ionized, lipid insoluble drug into urine (water soluable)

93
Q

What is Total Clearance (CL total )?

A

Represents the capacity for drug elimination by various organs
The volume of plasma cleared of a medication per unit of time (ml/min or L/hr)
defined as the volume of plasma cleared of a drug over a specified time period
Drug’s half life is used as a measure of drug clearance
Elimination kinetics play an essential role in drug clearance.

94
Q

What is First - order kinetics (linear kinetics) (exponential decrease)

A

Most drugs gets eliminated through this kinetics
A constant proportion of drug (%) is eliminated per unit of time
Absolute amount of drug eliminated is different
Rate of elimination is directly proportional to the concentration of drug
As the concentration of the drug drops, the rate of elimination of the drug will drop

95
Q

What is Zero-order (Non-linear elimination ) kinetics ?

A

Rate of drug elimination is independent of the concentration of the drugs
Absolute amount of drugs eliminated is the same per unit of time but not a proportion of drug.
Phenytoin or ethanol or warfarin, aspirin

96
Q

Half-life ( T½)

A

Time required for the drug concentration to be reduced by 50 %
Useful for estimating excretion rates and steady-state concentrations for any specific drug
Clinically relevant when determining the most efficient yet safest dosing schedule to achieve an optimal therapeutic effect
The clinical significance of half-life tends to arise in situations involving drug toxicity.
Renal impairment
Hepatic impairment

97
Q

What is a Steady-state concentration (Css)

A

A dynamic equilibrium in which drug concentrations consistently stay within therapeutic limits for long periods.
Rate of elimination = rate of administration
Occurs when the amount of a drug being absorbed is the same amount that’s being cleared from the body when the drug is given continuously or repeatedly.
Reaching a steady-state concentration is generally necessary for efficacy of drugs

98
Q

What is a drug’s half life used to measure?

A

Drug’s half life is used as a measure of drug clearance